XML 38 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)
3 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Consolidated Financial Statements

The tables below reflect the sections of the Company’s consolidated financial statements that were impacted by the error.

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

 

   As Reported   Adjustments   As Corrected 
   Three months ended September 30, 2023 
   As Reported   Adjustments   As Corrected 
             
Operating expenses               
General and administrative  $2,948,846   $105,152   $3,053,998 
Research and development   2,155,314    1,458,538    3,613,852 
Exploration   1,279,782    70,138    1,349,920 
Total operating expenses   6,383,942    1,633,828    8,017,770 
                
Net loss before other income (expense)  $(6,383,942)  $(1,633,828)  $(8,017,770)
                
Other income (expense)               
Amortization and accretion of financing costs  $(706,731)  $(26,165)  $(732,896)
Total other income (expense)   (848,042)   (26,165)   (874,207)
                
Net loss attributable to common stockholders  $(7,231,985)  $(1,659,992)  $(8,891,977)
Net loss per share, basic and diluted  $(0.16)  $(0.03)  $(0.19)

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

   Three months ended September 30, 2023 
   As Reported   Adjustments   As Corrected 
             
Stockholders’ Equity               
                
Additional paid-in capital:               
Stock-based compensation expense   1,921,442    1,447,827    3,369,269 
Balance, September 30, 2023  $226,317,285   $1,955,760   $228,273,045 
                
Accumulated deficit               
Net loss for period   (7,231,985)   (1,659,992)   (8,891,977)
Balance, September 30, 2023  $(167,205,560)  $(2,512,925)  $(169,718,485)
                
Total stockholders’ equity               
Balance, September 30, 2023  $59,195,532   $(557,166)  $58,638,366 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

   As Reported   Adjustments   As Corrected 
   Three months ended September 30, 2023 
   As Reported   Adjustments   As Corrected 
Operating Activities               
Net loss attributable to stockholders  $(7,231,985)  $(1,659,992)  $(8,891,977)
Adjustments to reconcile net loss to net cash used in operating activities:               
Amortization and accretion expense  $256,459   $26,165   $282,624 
Stock-based compensation   1,921,442    1,447,827    3,369,269 
Changes in operating assets and liabilities:               
Accounts payable and accrued liabilities  $228,071   $186,000   $414,071 
                
Net cash used in operating activities  $(4,758,984)  $-   $(4,758,984)